Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.5500
+0.0437 (8.63%)
At close: May 13, 2025, 4:00 PM
0.5300
-0.0200 (-3.64%)
Pre-market: May 14, 2025, 4:11 AM EDT

Verrica Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5163308113252298
Upgrade
Market Cap Growth
-83.84%-79.41%172.47%-55.17%-15.33%-27.31%
Upgrade
Enterprise Value
648826775216263
Upgrade
Last Close Price
0.550.707.322.759.1611.51
Upgrade
PS Ratio
4.908.3860.0912.5121.01-
Upgrade
PB Ratio
-2.74-6.4315.582.827.739.03
Upgrade
P/TBV Ratio
--15.582.827.739.03
Upgrade
EV/Sales Ratio
8.8711.5752.198.3217.98-
Upgrade
Debt / Equity Ratio
-2.28-4.662.300.041.331.13
Upgrade
Asset Turnover
0.130.110.080.140.16-
Upgrade
Inventory Turnover
5.608.37----
Upgrade
Quick Ratio
1.201.604.3510.051.531.66
Upgrade
Current Ratio
1.341.764.5511.311.611.71
Upgrade
Return on Equity (ROE)
--1546.58%-224.08%-67.42%-106.97%-87.13%
Upgrade
Return on Assets (ROA)
-62.87%-59.89%-62.56%-21.32%-25.04%-35.23%
Upgrade
Return on Capital (ROIC)
-94.99%-80.21%-73.97%-22.64%-26.42%-37.10%
Upgrade
Earnings Yield
-129.72%-120.80%-21.76%-21.67%-13.92%-14.34%
Upgrade
FCF Yield
-105.53%-96.15%-12.65%-16.77%-11.29%-10.64%
Upgrade
Buyback Yield / Dilution
-38.28%-14.26%-32.72%-26.32%-8.20%-0.39%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q